Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
The purpose of this study is to determine whether the lactic acid bacteria " Lactobacillus acidophilus (LA5) and Bifidobacterium animalis subsp. lactis (BB12)" is effective as maintenance treatment in ulcerative colitis.
Drug: lactobacilus acidophilus & bifidobacterium animalis/lactis
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis|
- Number of patients with relapse at 12 month.
- Number of days to relapse.
- Presence and concentrations of the probiotic bacterial strains in stool.
- Safety and tolerance of the probiotic mixture.
|Study Start Date:||June 2004|
|Study Completion Date:||March 2007|
|Primary Completion Date:||March 2007 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00268164
|Dept. of Medical Gastroenterology|
|Hvidovre, Denmark, 2650|
|Study Chair:||Flemming Bendtsen, MD, DMSci||Dept. of Medical Gastroenterology, Hvidovre University Hospital, Denmark|